Understanding the failure of CD8 T-cell vaccination against simian/human immunodeficiency virus

Although CD8+ T cells play an important role in controlling viral infections, boosting specific CD8+ T cells by prophylactic vaccination with simian immunodeficiency virus (SIV) epitopes fails to provide sterilizing immunity. Viral replication rates and viral contraction rates after the peak viremia hardly depend on the presence of memory CD8+ T cells. To study these paradoxical findings, we parameterize novel mathematical models for acute SIV and human immunodeficiency virus infection. These models explain that failure of vaccination is due to the fact that effector/target ratios are too low during the viral expansion phase. Because CD8+ T cells require cell-to-cell contacts, immune protection requires high effector/target ratios at the primary site of infection. Effector/target ratios become favorable for immune control at the time of the peak in the viral load when the virus becomes limited by other factors, such as the availability of uninfected target cells. At the viral set point, effector/target ratios are much higher, and perturbations of the number of CD8+ effector cells have a large impact on the viral load. Such protective effector/target ratios are difficult to achieve with nucleic acid- or protein-based vaccines.

[1]  Louis J. Picker,et al.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects , 2005, The Journal of experimental medicine.

[2]  Rustom Antia,et al.  Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells , 2002, The Journal of experimental medicine.

[3]  L. Segel,et al.  Extending the quasi-steady state approximation by changing variables. , 1996, Bulletin of mathematical biology.

[4]  R. Desrosiers,et al.  Immunization of Macaques with Single-Cycle Simian Immunodeficiency Virus (SIV) Stimulates Diverse Virus-Specific Immune Responses and Reduces Viral Loads after Challenge with SIVmac239 , 2005, Journal of Virology.

[5]  Philip J. R. Goulder,et al.  HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.

[6]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[7]  R. Steinman,et al.  A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum. , 2007, Frontiers in bioscience : a journal and virtual library.

[8]  D. Montefiori,et al.  Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge , 1999, Journal of Virology.

[9]  Alan S. Perelson,et al.  Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection , 2004, Journal of Virology.

[10]  Philippa Marrack,et al.  Epitope dominance, competition and T cell affinity maturation. , 2003, Current opinion in immunology.

[11]  M. Nowak,et al.  Virus dynamics: Mathematical principles of immunology and virology , 2001 .

[12]  Gary J. Nabel,et al.  Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys , 2006, Science.

[13]  L. Weinberger,et al.  Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.

[14]  G. Griffiths,et al.  The immunological synapse of CTL contains a secretory domain and membrane bridges. , 2001, Immunity.

[15]  A. Lackner,et al.  HIV swiftly guts the immune system , 2005, Nature Medicine.

[16]  D. Montefiori,et al.  A Combination DNA and Attenuated Simian Immunodeficiency Virus Vaccine Strategy Provides Enhanced Protection from Simian/Human Immunodeficiency Virus-Induced Disease , 2005, Journal of Virology.

[17]  J. Mcghee,et al.  HIV infection: first battle decides the war. , 2006, Trends in immunology.

[18]  Kendall C. Krebs,et al.  Cytotoxic T-Lymphocyte Escape Does Not Always Explain the Transient Control of Simian Immunodeficiency Virus SIVmac239 Viremia in Adenovirus-Boosted and DNA-Primed Mamu-A*01-Positive Rhesus Macaques , 2005, Journal of Virology.

[19]  Todd M. Allen,et al.  Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 Replication , 2002, Journal of Virology.

[20]  James G. Herndon,et al.  Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine , 2001, Science.

[21]  A. Khoruts,et al.  Naïve and Memory CD4+ T Cell Survival Controlled by Clonal Abundance , 2006, Science.

[22]  Sebastian Bonhoeffer,et al.  Glancing behind virus load variation in HIV-1 infection. , 2003, Trends in microbiology.

[23]  A S Perelson,et al.  Target cell limited and immune control models of HIV infection: a comparison. , 1998, Journal of theoretical biology.

[24]  Sebastian Bonhoeffer,et al.  Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.

[25]  Rolf M. Zinkernagel,et al.  What is missing in immunology to understand immunity? , 2000, Nature Immunology.

[26]  B. M. Flynn,et al.  Role of CD8+ Lymphocytes in Control of Simian Immunodeficiency Virus Infection and Resistance to Rechallenge after Transient Early Antiretroviral Treatment , 2001, Journal of Virology.

[27]  L. Cauley,et al.  Antiviral memory T-cell responses in the lung. , 2002, Microbes and infection.

[28]  David Montefiori,et al.  Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Montefiori,et al.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.

[30]  Ralph Weissleder,et al.  Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. , 2006, Immunity.

[31]  Kristin Beaudry,et al.  Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys , 2003, Journal of Virology.

[32]  A. Simon,et al.  Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.

[33]  David C Montefiori,et al.  Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants , 2005, Nature Immunology.

[34]  Qingsheng Li,et al.  Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells , 2005, Nature.

[35]  P D Griffiths,et al.  Population dynamics of HIV within an individual after treatment with zidovudine , 1991, AIDS.

[36]  A S Perelson,et al.  Resource competition determines selection of B cell repertoires. , 2001, Journal of theoretical biology.

[37]  A S Perelson,et al.  Towards a general function describing T cell proliferation. , 1995, Journal of theoretical biology.

[38]  Dominik Wodarz,et al.  Contrasting B cell- and T cell-based protective vaccines. , 2005, Journal of theoretical biology.

[39]  M. Nowak,et al.  Specific therapy regimes could lead to long-term immunological control of HIV. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Watkins,et al.  Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag , 2005, Journal of Virology.

[41]  Wei Lu,et al.  Therapeutic dendritic-cell vaccine for chronic HIV-1 infection , 2004, Nature Medicine.

[42]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[43]  P. Kahn Susceptibility Genes: Pointing a Way to Prevention? , 1996, Science.

[44]  Philippa Marrack,et al.  T cells down-modulate peptide-MHC complexes on APCs in vivo , 2002, Nature Immunology.

[45]  Katrina Walsh,et al.  Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost , 2005, Journal of Virology.

[46]  S. Staprans,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on March 1, 2013. For personal use , 2006 .

[47]  Dominik Wodarz,et al.  Direct quantitation of rapid elimination of viral antigen‐positive lymphocytes by antiviral CD8+ T cells in vivo , 2000, European journal of immunology.

[48]  Alan S. Perelson,et al.  Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.

[49]  J. Flamm,et al.  Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.

[50]  Philippa Marrack,et al.  T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells , 2000, The Journal of experimental medicine.

[51]  R. Zinkernagel,et al.  Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Desrosiers,et al.  Protective immunity induced by live attenuated simian immunodeficiency virus. , 1998, Current opinion in immunology.

[53]  Otto O. Yang,et al.  How Many Human Immunodeficiency Virus Type 1-Infected Target Cells Can a Cytotoxic T-Lymphocyte Kill? , 2005, Journal of Virology.

[54]  F. Miedema,et al.  T cell dynamics in HIV-1 infection. , 1999, Advances in immunology.

[55]  Sergei S. Pilyugin,et al.  Modeling immune responses with handling time , 2000, Bulletin of mathematical biology.

[56]  P. Doherty,et al.  The Collagen Binding α1β1 Integrin VLA-1 Regulates CD8 T Cell-Mediated Immune Protection against Heterologous Influenza Infection , 2004 .

[57]  E. Wherry,et al.  Cutting Edge: Rapid In Vivo Killing by Memory CD8 T Cells1 , 2003, The Journal of Immunology.

[58]  P. Marrack,et al.  CD8 T cell competition for dendritic cells in vivo is an early event in activation , 2006, Proceedings of the National Academy of Sciences.

[59]  D. Turner,et al.  Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. , 2006, Immunity.

[60]  Philip R. Johnson,et al.  HIV vaccine design: insights from live attenuated SIV vaccines , 2005, Nature Immunology.

[61]  H. K. Altes,et al.  The race between initial T–helper expansion and virus growth upon HIV infection influences polyclonality of the response and viral set–point , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[62]  J. Yin,et al.  Quantitative intracellular kinetics of HIV type 1. , 1999, AIDS research and human retroviruses.

[63]  A. Perelson,et al.  High-Potency Human Immunodeficiency Virus Vaccination Leads to Delayed and Reduced CD8+ T-Cell Expansion but Improved Virus Control , 2005, Journal of Virology.

[64]  A S Perelson,et al.  T cell repertoires and competitive exclusion. , 1994, Journal of theoretical biology.

[65]  Takahiro Hirata,et al.  Cytotoxic T Lymphocyte–based Control of Simian Immunodeficiency Virus Replication in a Preclinical AIDS Vaccine Trial , 2004, The Journal of experimental medicine.

[66]  Bin Li,et al.  HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. , 2006, Virology.

[67]  Rob J. De Boer,et al.  Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection , 2006, PLoS Comput. Biol..

[68]  Becca Asquith,et al.  A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. , 2005, The Journal of general virology.

[69]  Alan S. Perelson,et al.  Effect of drug efficacy and the eclipse phase of the viral life cycle on estimates of HIV viral dynamic parameters. , 2001 .

[70]  D. Montefiori,et al.  ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency , 2002, Journal of Virology.

[71]  A. Perelson,et al.  Predicting the Impact of a Nonsterilizing Vaccine against Human Immunodeficiency Virus , 2004, Journal of Virology.

[72]  Athanasius F. M. Marée,et al.  Small variations in multiple parameters account for wide variations in HIV–1 set–points: a novel modelling approach , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[73]  D. Watkins,et al.  Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239 , 2002, Journal of Virology.

[74]  M. Nowak,et al.  Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.

[75]  David Depoil,et al.  Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[76]  R. Kaul,et al.  HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi1 , 2000, The Journal of Immunology.

[77]  Alan S Perelson,et al.  Estimates of Intracellular Delay and Average Drug Efficacy from Viral Load Data of HIV-Infected Individuals under Antiretroviral Therapy , 2004, Antiviral therapy.

[78]  A. Perelson,et al.  Effects of in Vivo Cd8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine , 2000, The Journal of experimental medicine.

[79]  Henryk Mach,et al.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity , 2002, Nature.

[80]  Douglas D. Richman,et al.  Viral Dynamics of Acute HIV-1 Infection , 1999, The Journal of experimental medicine.

[81]  A. Tzafriri,et al.  The total quasi-steady-state approximation is valid for reversible enzyme kinetics. , 2004, Journal of theoretical biology.

[82]  Beda Joos,et al.  HIV replication elicits little cytopathic effects in vivo: Analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death , 2006, Journal of medical virology.

[83]  Wayne C Koff,et al.  HIV vaccine design and the neutralizing antibody problem , 2004, Nature Immunology.

[84]  Elazer R Edelman,et al.  On the validity of the quasi-steady state approximation of bimolecular reactions in solution. , 2005, Journal of theoretical biology.

[85]  Rustom Antia,et al.  Roles of Target Cells and Virus-Specific Cellular Immunity in Primary Simian Immunodeficiency Virus Infection , 2004, Journal of Virology.

[86]  M. Merkenschlager,et al.  Memory T cells , 1989, Nature.

[87]  E. Rosenberg,et al.  Immune control of HIV-1 after early treatment of acute infection , 2000, Nature.

[88]  D. Weiner,et al.  Long-Lasting Decrease in Viremia in Macaques Chronically Infected with Simian Immunodeficiency Virus SIVmac251 after Therapeutic DNA Immunization , 2006, Journal of Virology.

[89]  C. Boucher,et al.  Anti-CD4 therapy for AIDS suggested by mathematical models , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[90]  Andrew N. Phillips,et al.  Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.

[91]  J. Altman,et al.  Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. , 1998, Immunity.

[92]  David Montefiori,et al.  An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants , 2001, Cell.

[93]  H. Clifford Lane,et al.  Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques , 1998, Journal of Virology.

[94]  H. McClure,et al.  Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation , 2003, AIDS.

[95]  D. Montefiori,et al.  Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques. , 2005, Virology.

[96]  D. Montefiori,et al.  Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge , 2006, The Journal of experimental medicine.

[97]  R. Koup,et al.  Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.

[98]  L M Wahl,et al.  Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection , 1997, Journal of virology.

[99]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[100]  R. Zinkernagel Immunity, immunopathology and vaccines against HIV? , 2002, Vaccine.

[101]  R. Kaul,et al.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. , 2001, The Journal of clinical investigation.

[102]  D. Watkins,et al.  CD8+ T-Lymphocyte Response to Major Immunodominant Epitopes after Vaginal Exposure to Simian Immunodeficiency Virus: Too Late and Too Little , 2005, Journal of Virology.

[103]  I. M. Rouzine,et al.  Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[104]  J. Goedert,et al.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.

[105]  P. Doherty,et al.  Accessing complexity: the dynamics of virus-specific T cell responses. , 2000, Annual review of immunology.

[106]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.